On Invalid Date, Purple Biotech (NASDAQ: PPBT) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Purple Biotech earnings for the quarter were $4.83 million. In the same quarter last year, Purple Biotech's earnings per share (EPS) was N/A.
As of Q1 2024, Purple Biotech's earnings has grown year over year. Purple Biotech's earnings in the past year totalled $19.88 million.
What is PPBT's earnings date?
Purple Biotech's earnings date is Invalid Date. Add PPBT to your watchlist to be reminded of PPBT's next earnings announcement.
What was PPBT's revenue last quarter?
On Invalid Date, Purple Biotech (NASDAQ: PPBT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Purple Biotech's revenue was $0.00.
What was PPBT's revenue growth in the past year?
As of Q1 2024, Purple Biotech's revenue has grown null year over year. Purple Biotech's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.